Cardiology

Results showed that the intervention will be cost effective.

Results from the ongoing first large real-world evidence study of its kind published in the American Heart Association.

Study focused on type 2 diabetes patients who initiate metformin.

Study from Women's Health Initiative sought to determine whether low fasting glucose levels are associated with cardiovascular events and/or mortality.

In a departure from recommendations by cardiology societies, two endocrine groups issue new lipid-management guidelines that bring back LDL-cholesterol targets.

A new study found riding a bike to work associated with reduction in risk of cardiovascular disease, cancer risk, diabetes, and premature death over five years.

More rigorous screening called for to mitigate poor outcomes of this common condition.

Medication showed significant reduction in risk for cardiovascular death, hospitalization for worsening heart failure.

Are we experiencing the next “magic bullet” in type 2 diabetes?

New evidence questions the idea of what is normal.